Trial Profile
Clinical Trials Insight: 700029917
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2008
Price :
$35
*
At a glance
- Drugs Iclaprim (Primary) ; Vancomycin
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Arpida
- 19 Dec 2008 Top-line results announced in an Arpida media release.
- 19 Dec 2008 Top-line results announced in an Arpida media release.
- 23 Sep 2008 Status changed from recruiting to active, no longer recruiting as reported by Arpida.